Ionis Pharmaceuticals (IONS) Misses Q4 EPS by $2.72, Revenues Beat; Offers FY21 Revenue Guidance Below Consensus

Go back to Ionis Pharmaceuticals (IONS) Misses Q4 EPS by $2.72, Revenues Beat; Offers FY21 Revenue Guidance Below Consensus
(NASDAQ: IONS) Delayed: 57.24 +1.37 (2.45%)
Previous Close $55.87    52 Week High $62.68 
Open $55.16    52 Week Low $19.59 
Day High $57.24    P/E N/A 
Day Low $55.16    EPS $0.00 
Volume 1,353,738